Caina Technology Co

Caina Technology Co CapEx/D&A

The CapEx to Depreciation Ratio of Caina Technology Co (301122.SZ) as of Nov 4, 2026 is 12.75. In the previous year, CapEx to Depreciation Ratio was 38.03 — a change of -66.48% (lower).

CapEx/D&A

12.75

YoY

-66.48%

Last updated:

CapEx to Depreciation Ratio of Caina Technology Co is 2024 12.75 . CapEx to Depreciation Ratio of Caina Technology Co was 2023 38.03 . It decreases by -66.48% lower compared to the previous year.

The Caina Technology Co CapEx/D&A history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/D&A
Date
CapEx/D&A
Jan 1, 2018
6.71 CNY
Jan 1, 2019
13.87 CNY
Jan 1, 2020
15.00 CNY
Jan 1, 2021
19.81 CNY
Jan 1, 2022
34.85 CNY
Jan 1, 2023
38.03 CNY
Jan 1, 2024
12.75 CNY
The Caina Technology Co CapEx/D&A history
YEARCapEx/D&AYoY
12.75-66.48%
38.03+9.12%
34.85+75.99%
19.81+32.02%
15.00+8.15%
13.87+106.76%
6.71—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Caina Technology Co Stock analysis

What does Caina Technology Co do? Caina Technology Co., Ltd. manufactures medical consumables including puncture needles, syringes, laboratory consumables, and masks. The company's main products are reusable copper base injection needles, aluminum base injection needles, disposable aluminum-plastic inlaid injection needles, safety blood collection needles, sheathed syringes, disposable Sterile syringes, petri dishes, and reagent tubes. Caina Technology exports its products to the United States, the United Kingdom, and the European Union, serving international markets with its medical supplies. The company generates revenue through the sale of its medical consumables to global healthcare providers and distributors. Its product range targets hospitals, clinics, and laboratories requiring reliable medical equipment. Caina Technology's focus on exporting to developed markets ensures steady demand for its high-quality, compliant medical products. Caina Technology's business model relies on manufacturing and exporting medical consumables to international customers. The firm's product portfolio includes specialized items like safety blood collection needles and sterile syringes, which are essential for healthcare facilities. By targeting key regions such as the United States, United Kingdom, and European Union, the company secures consistent sales channels for its medical supplies. Caina Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Caina Technology Co stock

CapEx to Depreciation Ratio of Caina Technology Co is 12.75 in 2024.

CapEx to Depreciation Ratio of Caina Technology Co changed from 38.03 to 12.75, representing a -66.48% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Depreciation Ratio Caina Technology Co since 2006 – with annual values, charts, and detailed analysis.

The CapEx/D&A ratio compares investment spending to asset depreciation. Ratios above 1.0x indicate the company is growing its asset base, below 1.0x suggests underinvestment.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Depreciation Ratio's Caina Technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Depreciation Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Depreciation Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Caina Technology Co

All Key Metrics — Caina Technology Co